Polmacoxib (CG 100649) is a first-in-class NSAID drug candidate, is a dual inhibitor of carbonic anhydrase (CA) and COX-2. Polmacoxib inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation.
Molecular Weight:
361.39
Purity:
97.88%
CAS Number:
[301692-76-2]
Formula:
C18H16FNO4S
Target:
Carbonic Anhydrase|||COX
T21294
* VAT and and shipping costs not included. Errors and price changes excepted